Calcium sulfide nanoparticles as sustained H<sub>2</sub>S donors with neuroprotective potential in ischemic stroke.

Compared with NaHS treatment, CaS NPs showed a trend toward improved neurological outcomes, reduced infarct volume, and better preservation of neuronal structure; however, this comparison was exploratory.

also in 53,322 other papers